| CLPT Stock | | | USD 16.43 0.25 1.50% |
Clearpoint Neuro financial indicator trend analysis is way more than just evaluating Clearpoint Neuro prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clearpoint Neuro is a good investment. Please check the relationship between Clearpoint Neuro Roe and its Capex To Operating Cash Flow accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Clearpoint Stock please use our
How to Invest in Clearpoint Neuro guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Clearpoint Neuro Roe account and
Capex To Operating Cash Flow. At this time, the significance of the direction appears to have weak relationship.
The correlation between Clearpoint Neuro's Roe and Capex To Operating Cash Flow is 0.31. Overlapping area represents the amount of variation of Roe that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Clearpoint Neuro, assuming nothing else is changed. The correlation between historical values of Clearpoint Neuro's Roe and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roe of Clearpoint Neuro are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Roe i.e., Clearpoint Neuro's Roe and Capex To Operating Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.31 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Most indicators from Clearpoint Neuro's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clearpoint Neuro current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Clearpoint Stock please use our
How to Invest in Clearpoint Neuro guide.At this time, Clearpoint Neuro's
Sales General And Administrative To Revenue is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 165.8
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.5
M in 2024.
When running Clearpoint Neuro's price analysis, check to
measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to
predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.